NASDAQ: PYPD - PolyPid Ltd.

Lønnsomhet i seks måneder: -27.75%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan PolyPid Ltd.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet PolyPid Ltd.

PolyPid Ltd., a clinical-stage pharmaceutical company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which helps in the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2020-06-26
ISIN IL0011326795
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.polypid.com
Цена ао 4.84
Prisendring per dag: +1.4% (2.85)
Prisendring per uke: -10.25% (3.22)
Prisendring per måned: -16.35% (3.455)
Prisendring over 3 måneder: -20.17% (3.62)
Prisendring over seks måneder: -27.75% (4)
Prisendring per år: -23.95% (3.8)
Prisendring over 3 år: -49.48% (5.72)
Prisendring over 5 år: 0% (2.89)
Prisendring over 10 år: 0% (2.89)
Prisendring siden begynnelsen av året: -18.48% (3.545)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV -2.42 0
P/E 0 0
EV/EBITDA -0.5341 0
Total: 2.5

Effektivitet

Navn Betydning Karakter
ROA, % -155.25 0
ROE, % 1138.6 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.519 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % -30.61 0
Lønnsomhet EPS, % -4857.39 0
Total: 0
Flere detaljer

Institusjoner Volum Dele, %
Yelin Lapidot Holdings Management Ltd. 11153 0.23
Steward Partners Investment Advisory, LLC 7346 0.15
Morgan Stanley 878 0.02
Osaic Holdings Inc 800 0.02
UBS Group AG 764 0.02



Veileder Stillingstittel Betaling Fødselsår
Ms. Dikla Czaczkes Akselbrad CEO & Director 347.88k 1973 (52 år)
Ms. Dalit Hazan Deputy CEO and Executive VP of R&D, Clinical & Regulatory Affairs 272.38k 1971 (54 år)
Mr. Ori Warshavsky Chief Operating Officer - US 340.89k 1978 (47 år)
Mr. Jonny Missulawin Chief Financial Officer 186.96k 1987 (38 år)
Ms. Maria Rubin Vice President of Operations N/A
Mr. Tal Vilnai General Counsel & Corporate Secretary N/A
Ms. Rivi Lev-ari Vice President of Human Resource N/A
Dr. Jean-Marc Hagai Pharm.D. Chief Commercial Officer N/A

Adresse: Israel, Petah Tikva, 18 Hasivim Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.polypid.com